Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editor´s Picks
Indian and Chinese Drugmakers Dominate Asia Power Ranking(10/10/2017 )  (Premium)
How Shanghai Pharma Can Get High(10/10/2017 )  (Premium)
The Market
Sinohealth CMH: Review of Chinese Biopharmaceutical Market 2013-2016(10/13/2017 )  (Premium)
CPIIC: Hospital Drug Market Growth Down Substantially in H1/2017 and Leading Players by TCs in 2016(10/13/2017 )  (Premium)
Industry News
Harbour BioMed Licenses H2L2 Transgenic Mouse Platform for Four mAbs to Innovent Bio(10/13/2017 )  (Premium)
CFDA to Initiate Inspection of Biochemical Drug Manufacturing(10/11/2017 )  (Premium)
CSL Bets on Chinese Acquisition for China Supply Problems(10/9/2017 )  (Premium)
ADImmune Launches Flu Vaccine in Taiwan, Mainland China and the U.S.(10/9/2017 )  (free)
FountainVest Bids Against Shanghai Pharma for Cardinal's China Business(10/9/2017 )  (Premium)
Regulatory News
CFDA, NHFPC Issue Joint Announcement for Bioequivalence Study By Drug Clinical Trial Institutions(10/13/2017 )  (Premium)
CFDA Releases List of Reference Formulations for Generic Drug Equivalence Studies (9th and 10th Batches)(10/13/2017 )  (Premium)
Speech Made by CFDA Minister Bi at the National Conference for Drug Review and Approval System Reform(10/12/2017 )  (Premium)
CFDA Issues New Document on Adjustment of Import Drug Registration Related Matters(10/10/2017 )  (Premium)
General Health
Latest State Council Meeting Renews Public Hospital Reform Push(10/9/2017 )  (Premium)
Legal/IPR News
DSM Sinochem Pharma Sues Numerous Chinese API Firms for Patent Infringements(10/9/2017 )  (Premium)
People in the News
Recent Executive Moves(10/13/2017 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links